Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiad039 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Rajesh T Gandhi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: HIV-1, HIV Infections. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Abstract (Originalsprache)
Fourteen people with human immunodeficiency virus type 1 had longitudinal measurements of intact, defective, and total proviral DNA over the course of two decades of antiretroviral therapy. Three patterns of intact proviral DNA decay were revealed: (1) biphasic decline with markedly slower second-phase decline, (2) initial decline that transitions to a zero-slope plateau, and (3) initial decline followed by later increases in intact proviral DNA. Defective proviral DNA levels were essentially stable. Mechanisms of slowing or reversal of second-phase decay of intact proviral DNA may include the inability to clear cells with intact but transcriptionally silent proviruses and clonal expansion of cells with intact proviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Disease Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Accelevir Diagnostics, Baltimore, Maryland, USA.
- Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Frontier Science and Technology Research Foundation, Amherst, New York, USA.
- Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Small Business Innovation Research
- NIH Cooperative Agreement
- I4C Martin Delaney Collaboratory
- Beat-HIV Collaboratory
- National Science Foundation Small Business Innovation Research
Zitieren
APA
Gandhi, R. T., Bosch, R. J., Mar, H., Laird, G. M., Halvas, E. K., Hovind, L., Collier, A. C., Riddler, S. A., Martin, A., Ritter, K., McMahon, D. K., Eron, J. J., Cyktor, J. C., Mellors, J. W., & AIDS Clinical Trials Group A5321 Team (2023). Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad039
Vancouver
Gandhi RT, Bosch RJ, Mar H, Laird GM, Halvas EK, Hovind L, et al. Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad039
BibTeX
@article{Gandhi2023,
author = {Gandhi, Rajesh T and Bosch, Ronald J and Mar, Hanna and Laird, Gregory M and Halvas, Elias K and Hovind, Laura and Collier, Ann C and Riddler, Sharon A and Martin, Albine and Ritter, Kristen and McMahon, Deborah K and Eron, Joseph J and Cyktor, Joshua C and Mellors, John W and AIDS Clinical Trials Group A5321 Team, AIDS Clinical Trials Group A5321 Team},
title = {Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiad039}
}
EUVIMED